From treatable conditions to limb loss: gaps in clinical care pathways
Silas Onyango Awuor, Florence Awuor Ondiek
Corresponding author: Silas Onyango Awuor, Department of Microbiology, Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya 
Received: 19 May 2026 - Accepted: 28 Jun 2026 - Published: 03 Jul 2026
Domain: Bacteriology, Microbiology, Health information system management, Infection prevention and control
Keywords: Limb amputation, preventable amputation, clinical care pathways, diabetic foot ulcers, peripheral vascular disease, wound infections
Funding: This work received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
©Silas Onyango Awuor et al. PAMJ-One Health (ISSN: 2707-2800). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this article: Silas Onyango Awuor et al. From treatable conditions to limb loss: gaps in clinical care pathways. PAMJ-One Health. 2026;20:4. [doi: 10.11604/pamj-oh.2026.20.4.53474]
Available online at: https://www.one-health.panafrican-med-journal.com/content/article/20/4/full
From treatable conditions to limb loss: gaps in clinical care pathways
&Corresponding author
Limb amputation remains a disturbing yet often preventable outcome of common clinical conditions such as diabetic foot infections, peripheral vascular disease, and trauma. Despite advances in diagnostics, antimicrobial therapy, and surgical care, many patients continue to present with curable conditions but leave healthcare facilities with permanent disabilities. This commentary examines vital gaps in clinical care pathways, including delayed diagnosis, inadequate microbiological stewardship, antimicrobial resistance (AMR), and poor integration of multidisciplinary care that contribute to avoidable limb loss. Addressing these systemic failures through early intervention, strengthened laboratory capacity, coordinated care models, and robust antimicrobial stewardship programs is essential to reducing preventable amputations and improving patient outcomes.
Amputation is often regarded as a last-resort, life-saving intervention. However, in many healthcare settings, it reflects missed opportunities in prevention and early treatment. Patients frequently present with manageable conditions such as infected wounds, diabetic foot ulcers, or ischemic limbs yet progress to advanced disease requiring surgical removal of limbs [1,2]. This pattern underscores systemic weaknesses in clinical care pathways rather than solely disease severity. The burden is particularly pronounced in low- and middle-income countries (LMICs), where healthcare systems face constraints in diagnostics, workforce, and continuity of care [3]. Nevertheless, similar trends are increasingly reported globally, driven in part by the growing burden of chronic diseases and antimicrobial resistance [4,5].
Delayed diagnosis and fragmented care
Timely diagnosis is central to limb preservation. Yet many patients experience significant delays before receiving definitive care due to multiple referrals, limited access to specialized services, and inadequate early screening [6,7]. Fragmented care pathways further exacerbate the problem. Patients often move across different levels of care without coordinated management, resulting in delayed interventions and disease progression [8].
Microbiological gaps and antimicrobial resistance
Limited access to microbiological diagnostics forces reliance on empirical antibiotic therapy, which may be inappropriate [6]. This contributes to treatment failure and fuels antimicrobial resistance (AMR) [9,10]. Antimicrobial resistance (AMR) significantly worsens outcomes in wound infections and diabetic foot disease, increasing the likelihood of complications and amputation [6,9]. Without effective antimicrobial stewardship, this cycle continues to undermine clinical care.
Lack of multidisciplinary care models
Limb preservation requires coordinated, multidisciplinary care involving clinicians, microbiologists, surgeons, and wound care specialists. Evidence shows that such models reduce amputation rates, yet they remain inconsistently implemented, especially in resource-limited settings [1,6,7].
Missed opportunities in prevention
Preventive strategies such as early screening, patient education, and prompt treatment of minor wounds are often underutilized [2,10]. Socioeconomic barriers and delayed health-seeking behaviour further contribute to late presentations and poor outcomes [3].
The way forward
Reducing preventable amputations requires strengthening diagnostic and laboratory capacity [6,9], implementing antimicrobial stewardship programs [9,10], scaling multidisciplinary care models [1,7], enhancing preventive care and early intervention [2] and finally improving referral systems and continuity of care [10].
Limb loss should not be a common outcome of treatable conditions. Addressing gaps in clinical care pathways is essential to reducing preventable amputations and improving patient outcomes. This is both a clinical and public health priority.
The authors declare no competing interests.
Silas Onyango Awuor: conceptualization, resources, visualization. Silas Onyango Awuor and FAO: methodology, writing-original draft preparation, witing-review and editing, final editing. All the authors have read and approved the final version of this manuscript.
- Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367-75. PubMed | Google Scholar
- Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106-16. PubMed | Google Scholar
- Lipsky BA, Senneville E, Abbas ZG, Aragón-Sánchez J, Diggle M, Embil JM et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(S1):e3280. PubMed | Google Scholar
- World Health Organization. Antimicrobial resistance: global report on surveillance. Geneva: WHO; 2014. Google Scholar
- World Health Organization. Global action plan on antimicrobial resistance. Geneva: WHO; 2015. Google Scholar
- Lazzarini PA, Pacella RE, Armstrong DG, van Netten JJ. Diabetes-related lower-extremity complications are a leading cause of the global burden of disability. Diabet Med. 2018;35(9):1297-9. PubMed | Google Scholar
- Kerr M, Barron E, Chadwick P, Evans T, Kong WM, Rayman G et al. The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabet Med. 2019;36(8):995-1002. PubMed | Google Scholar
- Allegranzi B, Nejad SB, Combescure C, Graafmans W, Attar H, Donaldson L et al. Burden of endemic health-care-associated infection in developing countries. Lancet. 2011;377(9761):228-41. PubMed | Google Scholar
- Awuor SO, Omwenga EO, Mariita RM, Daud II. Cholera outbreak: antibiofilm activity, profiling of antibiotic-resistant genes and virulence factors of toxigenic Vibrio cholerae isolates reveals concerning traits. Access Microbiol. 2022;4(3):000324. PubMed | Google Scholar
- Sen CK. Human wounds and its burden: an updated compendium of estimates. Adv Wound Care. 2019;8(2):39-48. PubMed | Google Scholar



